Today, on September 30th, the Human Brain Project (HBP) formally completes its 10-year runtime as an EU-funded FET Flagship. Three HPB lead figures recount what has been achieved.
Environmental changes may reduce the diversity of mosquitos, but bring about a greater abundance of viruses, scientists from Charité in Berlin in cooperation with Leibniz-IZW find.
A new class of antibiotics, based on proven drugs used in cancer treatment, is now being developed by researchers at Linköping University. They could be used against resistant bacteria.
The commonly-held belief that attempting to suppress negative thoughts is bad for our mental health could be wrong, a new study from scientists at the University of Cambridge suggests.
Swiss scientists report that they have developed a gene therapy that was proven in mice to stimulate nerve regrowth across spinal cord injuries and guide nerves to reconnect to their natural targets.
A new onco-therapeutic vaccine candidate against human papillomavirus (HPV)-induced cancers, such as cervical and oropharyngeal cancers, has shown promising results in the preclinical phase.
A team at Politecnico di Milano developed iHEART, a mathematical and computational model of the human heart designed for studying coronary artery disease.
Engineers from MIT are developing a device containing insulin-producing cells and a tiny oxygen-producing factory to keep the cells of diabetes patients healthy.
A genetic test for BRCA1 or BRCA2 gene mutations may drive women to undergo breast cancer surgery, even though their risk might not even be drastically affected by this, a new study finds.
A newly discovered mechanism involving exosomes can drive inflammation and impair healing of wounds in diabetes patients, according to a new study led by University of Pittsburgh and UPMC researchers.
Half as thick as a human hair: Researchers at TU Munich have developed the world's first microrobot capable of navigating within groups of cells and stimulating individual cells.
A new nanocomplex renders a tumor harmless – and, on top of that, it trains the immune system to detect and eliminate metastases.
It had long been recognized that the brain was made up of two types of cells, neurons and glial cells. Now, neuroscientists discovered an additional type - with huge implications for brain disorders.
Cancer has become strikingly more common in people under 50 in the past three decades, an international research team finds. The reseachers explore what this means for future death tolls.
Where are the beginnings of breast cancer? A team of researchers at Kyoto University has revealed the mechanism by which breast cancer is formed in the cells of mammalian epithelium.
Spinal fusion is a highly invasive surgery where an implant is placed in the spine to prevent movement between bones. Currently, failure rate is high, but a new prototype device could change this.
New research from Lund University has found a suprisingly high incidence of sepsis across hospital admissions. The experts say that the condition can be likened to an epidemic.
Heatwaves, wildfires, flooding: effects of climate change will further exacerbate breathing difficulties for millions of people living with lung conditions, new research finds.
Can per- and polyfluoroalkyl substances (PFAS) increase the risk of breast cancer? A new study by US researchers examines the effects of the so-called “forever chemicals”.
New research finds the use of an electric field a promising means to prevent aerosol spread of viruses in healthcare environments, for example during surgery.
Two new studies based on a large-scale cohort in Denmark explored the side effects of the coronavirus vaccine – one focused on acute effects, the other on a women's health issue.
A new approach to treating kidney failure could one day free people from needing dialysis or having to take harsh drugs to suppress their immune system after a transplant.
Patients with immunodeficiency cannot benefit from conventional Covid-19 vaccines and still at risk from infection. A promising new approach now brings hope for this patient group.
A new analysis exploring the finances of bringing new cancer drugs to market has found that precision oncology drugs could be $1 billion cheaper to develop than non-precision drugs.
Brain tumour progression to a malignant state is believed to be the result of an intricate interplay between cancer cells and the tumour microenvironment. Greek researchers shed new light on the mechanisms.
